GeneDx Holdings Corp expected to post a loss of $2.80 a share - Earnings Preview

GeneDx Holdings

06/05/2023 03:05

* GeneDx Holdings Corp  WGS.OQ   WGS.O  is expected to show
a fall
in quarterly revenue when it reports  results on May 9. 
    * The Stamford Connecticut-based  company is expected to
report  a
29.5% decrease in revenue to $38.008 million from $53.94 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for GeneDx Holdings
Corp is
for a loss of $2.80 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for GeneDx
Holdings
Corp is $37.13​, above​ its last closing price of $8.55. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -4.84       -5.28      -8.25     Missed  -56.2
 Sep. 30 2022  -6.91       -7.01      -6.60     Beat    5.9
 Jun. 30 2022  -6.61       -6.93      -8.25     Missed  -19​
 Mar. 31 2022  -10.54      -10.19     -10.23    Missed  -0.4
 ​​Dec.        -8.45       -8.50      -5.61     Beat    34
 31 2021                                                
 Sep. 30 2021  -6.23       -6.20      -14.19    Missed  -128.7
                                                        ​
 This summary was machine generated May 6 at 02:05 GMT.  All
figures in US dollars  unless otherwise stated